Brief: China Regenerative Medicine International says Chen Chunguo re-designated as CEO
Feb 23 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK
* Shao Zhengkang has ceased to serve as chief executive
officer
* Chen Chunguo has been re-designated from president to
chief executive officer
Source text for Eikon: ID:nHKS7zFF80
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital